|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | |
| C07D 405/14 | |||
| C07D 213/75 | |||
| A61K 31/5585 | |||
| A61K 31/4418 | |||
| A61P 11/00 |
| (11) | Number of the document | 3208272 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16205718.6 |
| Date of filing the European patent application | 2006-11-08 | |
| (97) | Date of publication of the European application | 2017-08-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 734506 P | 2005-11-08 | US | |
| 754086 P | 2005-12-27 | US | |
| 802458 P | 2006-05-22 | US |
| (72) |
Hadida Ruah, Sarah, US
Hamilton, Matthew, US
Miller, Mark, US
Grootenhuis, Peter D. J., US
Bear, Brian, US
McCarthy, Jason, US
Zhou, Jinglan, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS |
| HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS |